c-kit point mutation of extracellular domain in patients with myeloproliferative disorders
- 1 November 1995
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 91 (3) , 661-663
- https://doi.org/10.1111/j.1365-2141.1995.tb05364.x
Abstract
Summary. c-kit is a tyrosine kinase receptor whose ligand is stem cell factor (SCF). Gene alteration of the c-kit extracellular domain was analysed by polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) in 25 patients with myeloproliferative disorders (MPD). In the N-terminal part of the domain, mobility shifts indicating sequence alteration were detected in three of the patients, two primary myelofibrosis (PMF) and one chronic myelogenous leukaemia (CML). The subsequent sequencing revealed the same point mutations at codon 52 causing amino acid substitution (Asp → Asn). To our knowledge this is the first report with a c-kit point mutation found in human fresh tumour cells.Keywords
This publication has 6 references indexed in Scilit:
- Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.Journal of Clinical Investigation, 1993
- Interspecies molecular chimeras of kit help define the binding site of the stem cell factor.Molecular and Cellular Biology, 1993
- Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reactionGenomics, 1989
- Colony formation by megakaryocytic progenitors in essential thrombocythaemiaBritish Journal of Haematology, 1987
- A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene familyNature, 1986
- Erythropoietin (Ep) dose-response curves for three classes of erythroid progenitors in normal human marrow and in patients with polycythemia veraBlood, 1978